For the dietary management of patients with or at risk of malnutrition in particular with cancer, chronic catabolic diseases and/or cachexia
Medical nutrition (FSMP)Other food registration2 registrations
Company: FRESENIUS KABI PHILIPPINES, INCLast updated:Audience: Licensed health professionals
Registered with the Philippine FDA as a FOOD FOR SPECIAL MEDICAL PURPOSES — for the dietary management of patients under medical supervision. Use with a physician's or dietitian's guidance; it is a food, not a drug.
Registered with the Philippine FDA as a food product; check the registration details for its stated use.
FDA Philippines registrations
2 current registrations (1 FSMP, 1 other food registration) under the brand SUPPORTAN. Registration status changes;
confirm a product's current status on the FDA verification portal using its FR number.
ORAL NUTRITIONAL SUPPLEMENT DRINK CAPPUCCINO FLAVOR - FOR THE DIETARY MANAGEMENT OF PATIENTS WITH OR AT RISK OF MALNUTRITION IN PARTICULAR WITH CANCER, CHRONIC CATABOLIC DISEASES AND/OR CACHEXIA
Composition
The FDA record names the food product, not its composition. Check the product label for protein, energy, potassium, phosphorus, sodium and sugar per serving.
For the dietary management of patients with or at risk of malnutrition in particular with cancer, chronic catabolic diseases and/or cachexia
Flavor
Cappuccino
Form
Liquid
Company
FRESENIUS KABI PHILIPPINES, INC
Issued
November 3, 2022
Valid until
May 21, 2027
FDA risk class
High Risk
Application
Automatic Amendment
ORAL NUTRITIONAL SUPPLEMENT FOODS FOR SPECIAL MEDICAL PURPOSE FOR THE DIETARY MANAGEMENT OF PATIENTS WITH OR AT RISK OF MALNUTRITION IN PARTICULAR WITH CANCER, CHRONIC CATABOLIC DISEASE AND/OR CACHEXIA
Composition
The FDA record names the product type and its registered use, not the full composition. Check the product label for protein, energy, potassium, phosphorus, sodium and fluid per serving.
For the dietary management of patients with or at risk of malnutrition in particular with cancer, chronic catabolic disease and/or cachexia
Form
Not stated in the FDA record
Company
FRESENIUS KABI PHILIPPINES, INC
Issued
April 7, 2022
Valid until
January 29, 2027
FDA risk class
High Risk
Application
Renewal Data Capture
For health professionals. Data come from the FDA Philippines food-product
registration database and may lag behind the official record. These registrations allow sale as foods (including foods for special medical purposes or special dietary use); none is a drug approval or an approval of safety or efficacy for any disease. Not a substitute for clinical judgment.